|
Volumn 32, Issue 10, 2003, Pages 820-825
|
Ongoing management of hepatitis C.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
HEPATITIS C ANTIBODY;
VIRUS RNA;
ALTERNATIVE MEDICINE;
ARTICLE;
AUSTRALIA;
DIET;
DISEASE TRANSMISSION;
FEMALE;
GENERAL PRACTICE;
HEPATITIS C;
HEPATITIS C VIRUS;
HOSPITALIZATION;
HUMAN;
ISOLATION AND PURIFICATION;
LIFESTYLE;
LONG TERM CARE;
MALE;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
PATIENT EDUCATION;
POLYMERASE CHAIN REACTION;
PROGNOSIS;
RISK ASSESSMENT;
SURVIVAL RATE;
ANTIVIRAL AGENTS;
AUSTRALIA;
COMBINED MODALITY THERAPY;
COMPLEMENTARY THERAPIES;
DIET;
DISEASE TRANSMISSION;
FAMILY PRACTICE;
FEMALE;
HEPACIVIRUS;
HEPATITIS C ANTIBODIES;
HEPATITIS C, CHRONIC;
HUMANS;
LIFE STYLE;
LONG-TERM CARE;
MALE;
PATIENT EDUCATION;
POLYMERASE CHAIN REACTION;
PROGNOSIS;
RISK ASSESSMENT;
RNA, VIRAL;
SEVERITY OF ILLNESS INDEX;
SURVIVAL RATE;
|
EID: 0642303764
PISSN: 03008495
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|